Jean-Claude Kyrillos insider trades: Tandem Diabetes Care (TNDM) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jean-Claude reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | TNDM | ↑ Buy | 10,538 | $18.12 | $191K | Direct | Mar 11, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TNDM insiders
Open-market trades in the last 12 months
About Jean-Claude Kyrillos's insider trades
Jean-Claude Kyrillos is EVP & Chief Operating Officer at Tandem Diabetes Care (TNDM). Since Mar 7, 2025, Jean-Claude has reported 1 open-market purchase worth $191K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings), shares withheld for taxes (10 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TNDM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.